173 related articles for article (PubMed ID: 16714069)
1. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus.
Lynch AM; Loane DJ; Minogue AM; Clarke RM; Kilroy D; Nally RE; Roche OJ; O'Connell F; Lynch MA
Neurobiol Aging; 2007 Jun; 28(6):845-55. PubMed ID: 16714069
[TBL] [Abstract][Full Text] [Related]
2. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid.
Minogue AM; Lynch AM; Loane DJ; Herron CE; Lynch MA
J Neurochem; 2007 Nov; 103(3):914-26. PubMed ID: 17711425
[TBL] [Abstract][Full Text] [Related]
3. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.
Clarke RM; O'Connell F; Lyons A; Lynch MA
Neuropharmacology; 2007 Jan; 52(1):136-45. PubMed ID: 16920163
[TBL] [Abstract][Full Text] [Related]
4. Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation.
Maher FO; Clarke RM; Kelly A; Nally RE; Lynch MA
J Neurochem; 2006 Mar; 96(6):1560-71. PubMed ID: 16464236
[TBL] [Abstract][Full Text] [Related]
5. The age-related attenuation in long-term potentiation is associated with microglial activation.
Griffin R; Nally R; Nolan Y; McCartney Y; Linden J; Lynch MA
J Neurochem; 2006 Nov; 99(4):1263-72. PubMed ID: 16981890
[TBL] [Abstract][Full Text] [Related]
6. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
Schmid AW; Lynch MA; Herron CE
Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
[TBL] [Abstract][Full Text] [Related]
7. Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus.
Moore M; Piazza A; Nolan Y; Lynch MA
Synapse; 2007 Oct; 61(10):851-61. PubMed ID: 17621647
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain.
Loane DJ; Deighan BF; Clarke RM; Griffin RJ; Lynch AM; Lynch MA
Neurobiol Aging; 2009 Jun; 30(6):920-31. PubMed ID: 17950491
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus.
Lonergan PE; Martin DS; Horrobin DF; Lynch MA
J Neurochem; 2004 Oct; 91(1):20-9. PubMed ID: 15379883
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation.
Kavanagh T; Lonergan PE; Lynch MA
Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):391-7. PubMed ID: 15041032
[TBL] [Abstract][Full Text] [Related]
11. A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat.
Martin DS; Walsh M; Miller AM; Skerrett HE; Byrne P; Mandel A; Bolton AE; Lynch MA
Neuroimmunomodulation; 2009; 16(6):400-10. PubMed ID: 19609089
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat.
Maher FO; Nolan Y; Lynch MA
Neurobiol Aging; 2005 May; 26(5):717-28. PubMed ID: 15708447
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
Cho JY; Kim HS; Kim DH; Yan JJ; Suh HW; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):901-7. PubMed ID: 15970368
[TBL] [Abstract][Full Text] [Related]
14. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
15. [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo.
Guo F; Jing W; Ma CG; Wu MN; Zhang JF; Li XY; Qi JS
Synapse; 2010 Jan; 64(1):83-91. PubMed ID: 19768812
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration.
Garção P; Oliveira CR; Agostinho P
J Neurosci Res; 2006 Jul; 84(1):182-93. PubMed ID: 16634056
[TBL] [Abstract][Full Text] [Related]
17. Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus.
Jin Y; Fan Y; Yan EZ; Liu Z; Zong ZH; Qi ZM
Acta Pharmacol Sin; 2006 Oct; 27(10):1309-16. PubMed ID: 17007737
[TBL] [Abstract][Full Text] [Related]
18. A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation.
Downer EJ; Cowley TR; Cox F; Maher FO; Berezin V; Bock E; Lynch MA
J Neurochem; 2009 Jun; 109(5):1516-25. PubMed ID: 19457161
[TBL] [Abstract][Full Text] [Related]
19. The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025.
Miller AM; Piazza A; Martin DS; Walsh M; Mandel A; Bolton AE; Lynch MA
Exp Gerontol; 2009 Apr; 44(4):300-4. PubMed ID: 19121379
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
Zhang JF; Qi JS; Qiao JT
Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
